Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis
Article in Dermatology and Therapy (October 2023)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
A review of biological agents and small molecules in the management of atopic dermatitis
Article in Indian Journal of Skin Allergy (October 2023)
Clinical trials of antibody drugs in the treatments of atopic dermatitis
Article in Frontiers in Medicine (September 2023)